ESC Professional Premium Access

The PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

Congress Session

About the speaker

Assistant Professor Guido Claessen

University Hospitals (UZ) Leuven, Leuven (Belgium)
7 presentations
0 follower

3 more presentations in this session

CKD-510, A Non-hydroxamic Acid Hdac6 Inhibitor, For Treatment Of Atrial Fibrillation.

Speaker: Doctor J. Lee (Yongin, KR)

Thumbnail

Ventricular Arrhythmic Risk Prediction in Low- and Moderate-risk Populations Using a Single-Lead ECG Heartbeat.

Speaker: Doctor J. Ramirez (Zaragoza, ES)

Thumbnail

Precision approaches to defining susceptibility to atrial fibrillation determine risk of cardioembolic stroke.

Speaker: Doctor P. Gajendragadkar (Oxford, GB)

Thumbnail

Access the full session

Basic and Translational Late-Breaking Science 2

Speakers: Assistant Professor G. Claessen, Doctor J. Lee, Doctor J. Ramirez, Doctor P. Gajendragadkar
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk